Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/65745
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response
Author: Domschke, K.
Lawford, B.
Laje, G.
Berger, K.
Young, R.
Morris, P.
Deckert, J.
Arolt, V.
McMahon, F.
Baune, B.
Citation: International Journal of Neuropsychopharmacology, 2010; 13(1):93-101
Publisher: Cambridge Univ Press
Issue Date: 2010
ISSN: 1461-1457
1469-5111
Statement of
Responsibility: 
Katharina Domschke, Bruce Lawford, Gonzalo Laje, Klaus Berger, Ross Young, Phillip Morris, Jürgen Deckert, Volker Arolt, Francis J. McMahon and Bernhard T. Baune
Abstract: The brain-derived neurotrophic factor (BDNF) has been suggested to play a pivotal role in the aetiology of affective disorders. In order to further clarify the impact of BDNF gene variation on major depression as well as antidepressant treatment response, association of three BDNF polymorphisms [rs7103411, Val66Met (rs6265) and rs7124442] with major depression and antidepressant treatment response was investigated in an overall sample of 268 German patients with major depression and 424 healthy controls. False discovery rate (FDR) was applied to control for multiple testing. Additionally, ten markers in BDNF were tested for association with citalopram outcome in the STAR*D sample. While BDNF was not associated with major depression as a categorical diagnosis, the BDNF rs7124442 TT genotype was significantly related to worse treatment outcome over 6 wk in major depression (p=0.01) particularly in anxious depression (p=0.003) in the German sample. However, BDNF rs7103411 and rs6265 similarly predicted worse treatment response over 6 wk in clinical subtypes of depression such as melancholic depression only (rs7103411: TT<CC, p=0.003; rs6265: GG<AA, p=0.001). All SNPs had main effects on antidepressant treatment response in ANOVA models when the remaining SNPs were considered as covariates. The STAR*D analyses did not yield significant results at any of the ten BDNF markers. Our results do not support an association between genetic variation in BDNF and antidepressant treatment response or remission. Post-hoc analyses provide some preliminary support for a potential minor role of genetic variation in BDNF and antidepressant treatment outcome in the context of melancholic depression.
Keywords: Antidepressant; BDNF; depression; neurotrophins; pharmacogenetics; STAR*D; treatment response.
Rights: Copyright © 2009 CINP
RMID: 0020111524
DOI: 10.1017/S1461145709000030
Appears in Collections:Psychiatry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.